Your browser doesn't support javascript.
loading
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.
Swarup, Vivek; Hinz, Flora I; Rexach, Jessica E; Noguchi, Ken-Ichi; Toyoshiba, Hiroyoshi; Oda, Akira; Hirai, Keisuke; Sarkar, Arjun; Seyfried, Nicholas T; Cheng, Chialin; Haggarty, Stephen J; Grossman, Murray; Van Deerlin, Vivianna M; Trojanowski, John Q; Lah, James J; Levey, Allan I; Kondou, Shinichi; Geschwind, Daniel H.
Afiliação
  • Swarup V; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Hinz FI; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Rexach JE; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Noguchi KI; CNS Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
  • Toyoshiba H; CNS Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
  • Oda A; CNS Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
  • Hirai K; CNS Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
  • Sarkar A; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Seyfried NT; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.
  • Cheng C; Alzheimer's Disease Research Center and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Haggarty SJ; Chemical Neurobiology Laboratory, Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Van Deerlin VM; Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Trojanowski JQ; The Penn FTD Center, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Lah JJ; The Penn FTD Center, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Levey AI; Alzheimer's Disease Research Center and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kondou S; Alzheimer's Disease Research Center and Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Geschwind DH; CNS Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.
Nat Med ; 25(1): 152-164, 2019 01.
Article em En | MEDLINE | ID: mdl-30510257
ABSTRACT
Identifying the mechanisms through which genetic risk causes dementia is an imperative for new therapeutic development. Here, we apply a multistage, systems biology approach to elucidate the disease mechanisms in frontotemporal dementia. We identify two gene coexpression modules that are preserved in mice harboring mutations in MAPT, GRN and other dementia mutations on diverse genetic backgrounds. We bridge the species divide via integration with proteomic and transcriptomic data from the human brain to identify evolutionarily conserved, disease-relevant networks. We find that overexpression of miR-203, a hub of a putative regulatory microRNA (miRNA) module, recapitulates mRNA coexpression patterns associated with disease state and induces neuronal cell death, establishing this miRNA as a regulator of neurodegeneration. Using a database of drug-mediated gene expression changes, we identify small molecules that can normalize the disease-associated modules and validate this experimentally. Our results highlight the utility of an integrative, cross-species network approach to drug discovery.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evolução Molecular / Doenças Neurodegenerativas / Demência / Redes Reguladoras de Genes Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evolução Molecular / Doenças Neurodegenerativas / Demência / Redes Reguladoras de Genes Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article